Has Jessica Stewart, MD received payments from drug or device companies?

Yes. Drug and device makers reported $253,929 in general payments to Jessica Stewart, MD across 345 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jessica Stewart, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jessica Stewart, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jessica Stewart, MD

Vascular & Interventional Radiology · Los Angeles, CANPI 1932487964

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.4%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Terumo Medical Corporation accounts for 61.5% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $169,611, more than ten times the $63 reported in 2019. Among vascular & interventional radiology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$253,929in general payments, 2019–2025

Across 345 payments — averaging $736.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Terumo Medical Corporation$156K
Siemens Medical Solutions USA, Inc.$45K
Medtronic$42K
Cook Incorporated$6K
Boston Scientific$1K
Penumbra, Inc.$873
plus $2K from 6 others

$68,453in research payments, 2019–2025

Across 18 payments — averaging $3802.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Terumo Medical Corporation$54K
Medtronic$8K
Vesper Medical$5K
Microvention, Inc.$2K

What the payments were for

Consulting fees$125,41449%
Speaking & faculty fees$49,96020%
Travel & lodging$67,84327%
Food & beverage$10,7134%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Terumo Medical Corporation	174	$156,130
Siemens Medical Solutions USA, Inc.	87	$45,350
Medtronic	35	$42,077
Cook Incorporated	4	$6,188
Boston Scientific	19	$1,451
Penumbra, Inc.	7	$873
Inari Medical, Inc.	6	$807
Johnson & Johnson	4	$407
Balt USA, LLC	4	$288
Bard Peripheral Vascular, Inc.	1	$147
Cook Medical LLC	2	$108
W. L. Gore & Associates, Inc.	2	$104

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$253,929 in reported general payments places this provider in the 95th percentile of 504 vascular & interventional radiology providers in California.

See all vascular & interventional radiology providers in California →

Medicare billing

Part B allowed, 2024

$87,222

Medicare patients

117

Services billed

1,985

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Los Angeles

Keith TerasakiLos Angeles$1.7M
Edward LeeLos Angeles$1.4M
Siddharth PadiaLos Angeles$960K
Satoshi TateshimaLos Angeles$764K
Navid EghbaliehLos Angeles$639K
John MoriartyLos Angeles$527K
Justin McWilliamsLos Angeles$265K
Evan LehrmanLos Angeles$218K
Steven RamanLos Angeles$211K
Ravi SrinivasaLos Angeles$130K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →